Skip to content

Generate Biomedicines, Inc. GENB Prepaid & Other Current

Prepaid & Other Current at other companies

MYR Group logo
MYR GroupMYRG
$51.04M+47.9%
Repligen logo
RepligenRGEN
$46.02M+32.6%
Piper Sandler logo
Piper SandlerPIPR
$19.68M+6.8%
ST
Sensata TechnologiesST
$152.4M-0.9%
AppFolio logo
AppFolioAPPF
$59.32M+75.8%
CHE
ChemedCHE
$26.91M-11.5%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's prepaid & other current?
Generate Biomedicines, Inc. (GENB) reported prepaid & other current of $18.75M in Q1 2026.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.